4.7 Review

Biomarkers Predictive of Metabolic Syndrome and Cardiovascular Disease in Childhood Cancer Survivors

期刊

JOURNAL OF PERSONALIZED MEDICINE
卷 12, 期 6, 页码 -

出版社

MDPI
DOI: 10.3390/jpm12060880

关键词

cancer survivors; metabolic syndrome; cardiovascular disease; childhood cancer; chemotherapy toxicity; radiotherapy toxicity; obesity

资金

  1. Fondazione per l'Oncologia Pediatrica

向作者/读者索取更多资源

The improvement in childhood cancer treatments has increased survival rates, but has also resulted in long-term side effects, with metabolic syndrome being one of the most frequent and leading to high mortality. Therefore, early diagnosis strategies are necessary.
The improvement in childhood cancer treatments resulted in a marked improvement in the survival of pediatric cancer patients. However, as survival increased, it was also possible to observe the long-term side effects of cancer therapies. Among these, metabolic syndrome is one of the most frequent long-term side effects, and causes high mortality and morbidity. Consequently, it is necessary to identify strategies that allow for early diagnosis. In this review, the pathogenetic mechanisms of metabolic syndrome and the potential new biomarkers that can facilitate its diagnosis in survivors of pediatric tumors are analyzed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据